Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry

•Direct infusion mass spectrometry allows comprehensive lipidomic fingerprinting.•Numerous lipids and metabolites are altered in serum of Alzheimer's disease.•Potential biomarkers can be associated with important hallmarks of Alzheimer's disease.•Membrane breakdown highlights as a key fact...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical and biomedical analysis 2014-09, Vol.98, p.321-326
Main Authors: González-Domínguez, R., García-Barrera, T., Gómez-Ariza, J.L.
Format: Article
Language:English
Subjects:
Aged
Alzheimer Disease - blood
Alzheimer Disease - metabolism
Alzheimer's disease
Biomarkers
Biomarkers - blood
Biomarkers - chemistry
Biomarkers - metabolism
Direct infusion mass spectrometry
Female
Humans
Lipidomics
Lipids - blood
Lipids - chemistry
Male
Mass Spectrometry
Metabolic Networks and Pathways - physiology
Metabolome - physiology
Metabolomics - methods
Multivariate Analysis
Serum - chemistry
Serum - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Direct infusion mass spectrometry allows comprehensive lipidomic fingerprinting.•Numerous lipids and metabolites are altered in serum of Alzheimer's disease.•Potential biomarkers can be associated with important hallmarks of Alzheimer's disease.•Membrane breakdown highlights as a key factor in development of Alzheimer's disease.•Several novel biomarkers were found: diacylglycerols, oleamide and other metabolites. In this study, we demonstrated the potential of direct infusion mass spectrometry for the lipidomic characterization of Alzheimer's disease. Serum samples were extracted for lipids recovery, and directly analyzed using an electrospray source. Metabolomic fingerprints were subjected to multivariate analysis in order to discriminate between groups of patients and healthy controls, and then some key-compounds were identified as possible markers of Alzheimer's disease. Major differences were found in lipids, although some low molecular weight metabolites also showed significant changes. Thus, important metabolic pathways involved in neurodegeneration could be studied on the basis of these perturbations, such as membrane breakdown (phospholipids and diacylglycerols), oxidative stress (prostaglandins, imidazole and histidine), alterations in neurotransmission systems (oleamide and putrescine) and hyperammonaemia (guanidine and arginine). Moreover, it is noteworthy that some of these potential biomarkers have not been previously described for Alzheimer's disease.
ISSN:0731-7085
1873-264X
DOI:10.1016/j.jpba.2014.05.023